Overview

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia

Status:
Completed

Trial end date:
1997-03-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the safety and efficacy of risperidone (an antipsychotic medication) versus placebo in the treatment of behavioral disturbances associated with dementia.

Phase:

Phase 3

Details

Lead Sponsor:

Janssen, LP

Treatments:

Risperidone